Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Linder

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Oncotarget|February 26, 2015
Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapyOtto Hemminki, Suvi Parviainen, Juuso Juhila, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 28, 2015
Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic AdenovirusKristian Taipale, Ilkka Liikanen, Juuso Juhila, et al.
Ebiomedicine|July 19, 2020
Fetal HLA-G mediated immune tolerance and interferon response in preeclampsiaSatu Wedenoja, Masahito Yoshihara, Hindrek Teder, et al.
The Journal of Pathology|February 15, 2018
Spatial aspects of oncogenic signalling determine the response to combination therapy in slice explants from Kras-driven lung tumoursKatja Närhi, Ashwini S Nagaraj, Elina Parri, et al.
Oncoimmunology|May 6, 2015
Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8<sup>+</sup> T-cell response, prominent infiltration of CD8<sup>+</sup> lymphocytes and Th1 type polarizationTuuli Ranki, Timo Joensuu, Elke Jäger, et al.
Journal for Immunotherapy of Cancer|March 17, 2016
Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markersTuuli Ranki, Sari Pesonen, Akseli Hemminki, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Oncotarget|February 26, 2015
Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapyOtto Hemminki, Suvi Parviainen, Juuso Juhila, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 28, 2015
Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic AdenovirusKristian Taipale, Ilkka Liikanen, Juuso Juhila, et al.
Ebiomedicine|July 19, 2020
Fetal HLA-G mediated immune tolerance and interferon response in preeclampsiaSatu Wedenoja, Masahito Yoshihara, Hindrek Teder, et al.
The Journal of Pathology|February 15, 2018
Spatial aspects of oncogenic signalling determine the response to combination therapy in slice explants from Kras-driven lung tumoursKatja Närhi, Ashwini S Nagaraj, Elina Parri, et al.
Oncoimmunology|May 6, 2015
Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8<sup>+</sup> T-cell response, prominent infiltration of CD8<sup>+</sup> lymphocytes and Th1 type polarizationTuuli Ranki, Timo Joensuu, Elke Jäger, et al.
Journal for Immunotherapy of Cancer|March 17, 2016
Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markersTuuli Ranki, Sari Pesonen, Akseli Hemminki, et al.
Pageof 5